Latest Business and People News


Applied Clinical Trials

Updated employee announcements, business news, awards, and recognition in the industry today.

People News

Saama Technologies, Inc., a big data and analytics solutions company, announced that Mehdi Benchoufi, M.D., Assistant Professor in the Clinical Epidemiology Center at Hôtel-Dieu Hospital, University Paris Descartes, has joined its Board of Advisors.

Bio-Optronics, the maker of the Clinical Conductor Clinical Trial Management System, announces the appointment of Sujay Jadhav to its Board of Directors.

LabConnect, LLC, a global provider of central laboratory and support services for biopharmaceutical, medical device, and CROs, announces the promotion of three executives to top-level management positions: Barry Simms, MBA, as Chief Operating Officer, Trenton Harris, MSM/MBA, as Executive Vice President and Elizabeth Koury, MS, as Vice President, scientific affairs.

Clinipace, a global full-service CRO, expands its leadership team by appointing Dawn Sauro as Chief Development Officer and Sharon Moore as Chief Medical Officer.

InClinica, a global clinical CRO, announced that Jeffrey Schwartz has been appointed Assistant Vice President of Business Development and Anthony J. Esposito, Jr. has been appointed Senior Director of Quality Assurance.


Business News

Veeva Systems, a cloud-based solutions provider, announced that 12 adapters including a top 20 pharmaceutical company and CROs are now using Veeva Vault EDC to improve data management in their clinical trials.

Novotech, an Asia-Pacific CRO, announced that it has signed Memorandum of Understandings with five medical institutions in the region.

Clinipace, a global full-service CRO, expands its leadership team and launches a new brand identity, CHALLENGE ACCEPTED, to support its future growth as a midsized CRO.

proinnovera GmbH, a full service CRO, announced the establishment of the Company’s wholly owned subsidiary, proinnovera Inc. in North Carolina.



Certara, a drug development consultancy, served as a key member of the MDGH drug development team when they were granted FDA approval for moxidectin for river blindness.

Navitas Life Sciences, a full service Clinical, Regulatory & Safety solutions and services provider, announced that it has been recognized as a ‘Leader’ in the IDC MarketScape: Worldwide Life Science R&D BPO Services 2018 Vendor Assessment.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.